Variant Bio Partners With Pharma For Drug Development
Variant Bio is targeting the community more broadly, drawing participants from it. The organization has a unique benefit-sharing program that aims to provide financial benefits to the community through its findings.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
KQED FM
“that variant bio does is targeting the community more broadly that participants are drawn from. So we have a unique benefit sharing program that”
KQED FM
“We've partnered with large pharmaceutical companies like Novo and Bairnger Engel. to get those findings into their hands so that they can develop life-saving drugs and progress those. That's led to revenue for variant bio, and that revenue is already being shared with our partner communities around the globe.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade